Athersys And To Collaborate On MultiStem Commercial Manufacturing In Japan

Athersys’ collaborator, HEALIOS K.K. (Healios), has an exclusive license to develop and market MultiStem in Japan for ischemic stroke … our ability to protect our intellectual property portfolio; our possible inability to execute our strategy due …
( read original story …)


Related Post

Japan inflation ticks up in April as oil prices re...
views 103
Japan's core consumer price index climbed to a two...
Japanese remain loyal to past business
views 61
Though Japanese investors do not regard Slovakia a...
Tokyo to get Japan's first Moxy in November
views 92
Tokyo-based commercial real estate developer Pacif...
Japanese freelancer feels Tokyo gave short shrift ...
views 84
Early on the morning of Feb. 1, 2015, Japan woke t...
Tokyo stocks open lower as US election jitters boo...
views 83
Tokyo stocks opened lower on Friday as investor ji...
Sharp in legal battle with Hisense over patents as...
views 42
The Osaka-based Sharp plans to be more assertive w...
Nikkei rebounds as U.S. debt ceiling deal helps ri...
views 69
TOKYO, Sept 7 (Reuters) - Japan’s Nikkei share ave...
Airbnb’s Chinese Rival Tujia Is Also Focusing on B...
views 33
Japan may be Airbnb’s most popular country in Asia...
Surge in visitors to Japan attributed to S. Korean...
views 57
TOKYO - The surge of foreign visitors to Japan in ...
DIARY-Top Economic Events to Feb. 28
views 89
KOCHI, Japan - Bank of Japan Deputy Governor Hiros...